Patents by Inventor Gustav Gaudernack

Gustav Gaudernack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6090935
    Abstract: The invention provides a method for isolating nucleic acid from a sample, said method comprising boiling said sample and allowing it to cool, and condensing the nucleic acid onto a high-surface area solid support, and in particular the use of such a method in the preparation of nucleic acid samples for subsequent amplification. The method has particular utility in the isolation of nucleic acid from aged, fixed or otherwise distressed samples.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: July 18, 2000
    Assignee: Medinnova SF
    Inventors: Jarle Breivik, Gustav Gaudernack, Anne Spurkland
  • Patent number: 6090546
    Abstract: The invention relates to an oligonucleotide primer sequence for use in in vitro amplification, characterised in that said primer sequence is capable of creating a BstX I restriction site overlapping codon (12) and/or an Xcm I restriction site overlapping codon (13) or a Bce 83I restriction site overlapping codon (61) of the wild-type K-ras oncogene, methods of using said primer sequences for detecting activating mutations in codons (12 and/or 13 and/or 61) of the K-ras oncogene and kits for performing the methods.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: July 18, 2000
    Assignee: Medinnova SF
    Inventors: Jarle Breivik, Gustav Gaudernack
  • Patent number: 5961978
    Abstract: Synthetic peptides and fragments of oncogene protein products which elicit T cellular immunity, for use in cancer vaccines and compositions for anti-cancer treatment.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: October 5, 1999
    Assignee: Norsk Hydro, a.s.
    Inventors: Gustav Gaudernack, Tobias Gedde-Dahl, Jon Amund Eriksen